Home >> Life Sciences >> Healthcare

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Radiopharmaceutical Market 2017 Forecast to 2022

Published: Apr-2017 | Format: PDF | Global Info Research | Number of pages: 122 | Code: MRS - 121717

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Scope of the Report:
This report focuses on the Radiopharmaceutical in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
    Bayer
    Triad Isotopes
    Lantheus
    GE Healthcare
    Mallinckrodt
    Eli Lilly
    Bracco Imaging
    SIEMENS
    Navidea
    Nordion
    IBA Group
    Jubilant Pharma

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
    Diagnostic Radioisotopes
    Therapeutic Radioisotopes

Market Segment by Applications, can be divided into
    Oncology
    Cardiology
    Other

There are 15 Chapters to deeply display the global Radiopharmaceutical market.

Chapter 1, to describe Radiopharmaceutical Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Radiopharmaceutical, with sales, revenue, and price of Radiopharmaceutical, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Radiopharmaceutical, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Radiopharmaceutical market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Radiopharmaceutical sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents
1 Market Overview
    1.1 Radiopharmaceutical Introduction
    1.2 Market Analysis by Type
        1.2.1 Diagnostic Radioisotopes
        1.2.2 Therapeutic Radioisotopes
    1.3 Market Analysis by Applications
        1.3.1 Oncology
        1.3.2 Cardiology
        1.3.3 Other
    1.4 Market Analysis by Regions
        1.4.1 North America (USA, Canada and Mexico)
            1.4.1.1 USA Market States and Outlook (2012-2022)
            1.4.1.2 Canada Market States and Outlook (2012-2022)
            1.4.1.3 Mexico Market States and Outlook (2012-2022)
        1.4.2 Europe (Germany, France, UK, Russia and Italy)
            1.4.2.1 Germany Market States and Outlook (2012-2022)
            1.4.2.2 France Market States and Outlook (2012-2022)
            1.4.2.3 UK Market States and Outlook (2012-2022)
            1.4.2.4 Russia Market States and Outlook (2012-2022)
            1.4.2.5 Italy Market States and Outlook (2012-2022)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
            1.4.3.1 China Market States and Outlook (2012-2022)
            1.4.3.2 Japan Market States and Outlook (2012-2022)
            1.4.3.3 Korea Market States and Outlook (2012-2022)
            1.4.3.4 India Market States and Outlook (2012-2022)
            1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
        1.4.4 South America, Middle East and Africa
            1.4.4.1 Brazil Market States and Outlook (2012-2022)
            1.4.4.2 Egypt Market States and Outlook (2012-2022)
            1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
            1.4.4.4 South Africa Market States and Outlook (2012-2022)
            1.4.4.5 Nigeria Market States and Outlook (2012-2022)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 Bayer
        2.1.1 Business Overview
        2.1.2 Radiopharmaceutical Type and Applications
            2.1.2.1 Type 1
            2.1.2.2 Type 2
        2.1.3 Bayer Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2 Triad Isotopes
        2.2.1 Business Overview
        2.2.2 Radiopharmaceutical Type and Applications
            2.2.2.1 Type 1
            2.2.2.2 Type 2
        2.2.3 Triad Isotopes Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3 Lantheus
        2.3.1 Business Overview
        2.3.2 Radiopharmaceutical Type and Applications
            2.3.2.1 Type 1
            2.3.2.2 Type 2
        2.3.3 Lantheus Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4 GE Healthcare
        2.4.1 Business Overview
        2.4.2 Radiopharmaceutical Type and Applications
            2.4.2.1 Type 1
            2.4.2.2 Type 2
        2.4.3 GE Healthcare Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5 Mallinckrodt
        2.5.1 Business Overview
        2.5.2 Radiopharmaceutical Type and Applications
            2.5.2.1 Type 1
            2.5.2.2 Type 2
        2.5.3 Mallinckrodt Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6 Eli Lilly
        2.6.1 Business Overview
        2.6.2 Radiopharmaceutical Type and Applications
            2.6.2.1 Type 1
            2.6.2.2 Type 2
        2.6.3 Eli Lilly Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7 Bracco Imaging
        2.7.1 Business Overview
        2.7.2 Radiopharmaceutical Type and Applications
            2.7.2.1 Type 1
            2.7.2.2 Type 2
        2.7.3 Bracco Imaging Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8 SIEMENS
        2.8.1 Business Overview
        2.8.2 Radiopharmaceutical Type and Applications
            2.8.2.1 Type 1
            2.8.2.2 Type 2
        2.8.3 SIEMENS Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9 Navidea
        2.9.1 Business Overview
        2.9.2 Radiopharmaceutical Type and Applications
            2.9.2.1 Type 1
            2.9.2.2 Type 2
        2.9.3 Navidea Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10 Nordion
        2.10.1 Business Overview
        2.10.2 Radiopharmaceutical Type and Applications
            2.10.2.1 Type 1
            2.10.2.2 Type 2
        2.10.3 Nordion Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.11 IBA Group
        2.11.1 Business Overview
        2.11.2 Radiopharmaceutical Type and Applications
            2.11.2.1 Type 1
            2.11.2.2 Type 2
        2.11.3 IBA Group Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.12 Jubilant Pharma
        2.12.1 Business Overview
        2.12.2 Radiopharmaceutical Type and Applications
            2.12.2.1 Type 1
            2.12.2.2 Type 2
        2.12.3 Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Radiopharmaceutical Market Competition, by Manufacturer
    3.1 Global Radiopharmaceutical Sales and Market Share by Manufacturer (2016-2017)
    3.2 Global Radiopharmaceutical Revenue and Market Share by Manufacturer (2016-2017)
    3.3 Global Radiopharmaceutical Price by Manufacturer (2016-2017)
    3.4 Market Concentration Rate
        3.4.1 Top 3 Radiopharmaceutical Manufacturer Market Share
        3.4.2 Top 5 Radiopharmaceutical Manufacturer Market Share
    3.5 Market Competition Trend
4 Global Radiopharmaceutical Market Analysis by Regions
    4.1 Global Radiopharmaceutical Sales, Revenue and Market Share by Regions
        4.1.1 Global Radiopharmaceutical Sales by Regions (2012-2017)
        4.1.2 Global Radiopharmaceutical Revenue by Regions (2012-2017)
    4.2 North America Radiopharmaceutical Sales and Growth (2012-2017)
    4.3 Europe Radiopharmaceutical Sales and Growth (2012-2017)
    4.4 Asia-Pacific Radiopharmaceutical Sales and Growth (2012-2017)
    4.5 South America Radiopharmaceutical Sales and Growth (2012-2017)
    4.6 Middle East and Africa Radiopharmaceutical Sales and Growth (2012-2017)
5 North America Radiopharmaceutical by Countries, Type, Application and Manufacturers
    5.1 North America Radiopharmaceutical Sales, Revenue and Market Share by Countries
        5.1.1 North America Radiopharmaceutical Sales by Countries (2012-2017)
        5.1.2 North America Radiopharmaceutical Revenue by Countries (2012-2017)
        5.1.3 USA Radiopharmaceutical Sales and Growth (2012-2017)
        5.1.4 Canada Radiopharmaceutical Sales and Growth (2012-2017)
        5.1.5 Mexico Radiopharmaceutical Sales and Growth (2012-2017)
    5.2 North America Radiopharmaceutical Sales and Revenue (value) by Manufacturers (2016-2017)
        5.2.1 North America Radiopharmaceutical Sales by Manufacturers (2016-2017)
        5.2.2 North America Radiopharmaceutical Revenue by Manufacturers (2016-2017)
    5.3 North America Radiopharmaceutical Sales by Type (2012-2017)
    5.4 North America Radiopharmaceutical Sales by Application (2012-2017)
6 Europe Radiopharmaceutical by Countries, Type, Application and Manufacturers
    6.1 Europe Radiopharmaceutical Sales, Revenue and Market Share by Countries
        6.1.1 Europe Radiopharmaceutical Sales by Countries (2012-2017)
        6.1.2 Europe Radiopharmaceutical Revenue by Countries (2012-2017)
        6.1.3 Germany Radiopharmaceutical Sales and Growth (2012-2017)
        6.1.4 UK Radiopharmaceutical Sales and Growth (2012-2017)
        6.1.5 France Radiopharmaceutical Sales and Growth (2012-2017)
        6.1.6 Russia Radiopharmaceutical Sales and Growth (2012-2017)
        6.1.7 Italy Radiopharmaceutical Sales and Growth (2012-2017)
    6.2 Europe Radiopharmaceutical Sales and Revenue (value) by Manufacturers (2016-2017)
        6.2.1 Europe Radiopharmaceutical Sales by Manufacturers (2016-2017)
        6.2.2 Europe Radiopharmaceutical Revenue by Manufacturers (2016-2017)
    6.3 Europe Radiopharmaceutical Sales by Type (2012-2017)
    6.4 Europe Radiopharmaceutical Sales by Application (2012-2017)
7 Asia-Pacific Radiopharmaceutical by Countries, Type, Application and Manufacturers
    7.1 Asia-Pacific Radiopharmaceutical Sales, Revenue and Market Share by Countries
        7.1.1 Asia-Pacific Radiopharmaceutical Sales by Countries (2012-2017)
        7.1.2 Asia-Pacific Radiopharmaceutical Revenue by Countries (2012-2017)
        7.1.3 China Radiopharmaceutical Sales and Growth (2012-2017)
        7.1.4 Japan Radiopharmaceutical Sales and Growth (2012-2017)
        7.1.5 Korea Radiopharmaceutical Sales and Growth (2012-2017)
        7.1.6 India Radiopharmaceutical Sales and Growth (2012-2017)
        7.1.7 Southeast Asia Radiopharmaceutical Sales and Growth (2012-2017)
    7.2 Asia-Pacific Radiopharmaceutical Sales and Revenue (value) by Manufacturers (2016-2017)
        7.2.1 Asia-Pacific Radiopharmaceutical Sales by Manufacturers (2016-2017)
        7.2.2 Asia-Pacific Radiopharmaceutical Revenue by Manufacturers (2016-2017)
    7.3 Asia-Pacific Radiopharmaceutical Sales by Type (2012-2017)
    7.4 Asia-Pacific Radiopharmaceutical Sales by Application (2012-2017)
8 South America Radiopharmaceutical by Countries, Type, Application and Manufacturers
    8.1 South America Radiopharmaceutical Sales, Revenue and Market Share by Countries
        8.1.1 South America Radiopharmaceutical Sales by Countries (2012-2017)
        8.1.2 South America Radiopharmaceutical Revenue by Countries (2012-2017)
        8.1.3 Brazil Radiopharmaceutical Sales and Growth (2012-2017)
        8.1.4 Argentina Radiopharmaceutical Sales and Growth (2012-2017)
        8.1.5 Columbia Radiopharmaceutical Sales and Growth (2012-2017)
    8.2 South America Radiopharmaceutical Sales and Revenue (value) by Manufacturers (2016-2017)
        8.2.1 South America Radiopharmaceutical Sales by Manufacturers (2016-2017)
        8.2.2 South America Radiopharmaceutical Revenue by Manufacturers (2016-2017)
    8.3 South America Radiopharmaceutical Sales by Type (2012-2017)
    8.4 South America Radiopharmaceutical Sales by Application (2012-2017)
9 Middle East and Africa Radiopharmaceutical by Countries, Type, Application and Manufacturers
    9.1 Middle East and Africa Radiopharmaceutical Sales, Revenue and Market Share by Countries
        9.1.1 Middle East and Africa Radiopharmaceutical Sales by Countries (2012-2017)
        9.1.2 Middle East and Africa Radiopharmaceutical Revenue by Countries (2012-2017)
        9.1.3 Saudi Arabia Radiopharmaceutical Sales and Growth (2012-2017)
        9.1.4 UAE Radiopharmaceutical Sales and Growth (2012-2017)
        9.1.5 Egypt Radiopharmaceutical Sales and Growth (2012-2017)
        9.1.6 Nigeria Radiopharmaceutical Sales and Growth (2012-2017)
        9.1.7 South Africa Radiopharmaceutical Sales and Growth (2012-2017)
    9.2 Middle East and Africa Radiopharmaceutical Sales and Revenue (value) by Manufacturers (2016-2017)
        9.2.1 Middle East and Africa Radiopharmaceutical Sales by Manufacturers (2016-2017)
        9.2.2 Middle East and Africa Radiopharmaceutical Revenue by Manufacturers (2016-2017)
    9.3 Middle East and Africa Radiopharmaceutical Sales by Type (2012-2017)
    9.4 Middle East and Africa Radiopharmaceutical Sales by Application (2012-2017)
10 Global Radiopharmaceutical Market Segment by Type
    10.1 Global Radiopharmaceutical Sales, Revenue and Market Share by Type (2012-2017)
        10.1.1 Global Radiopharmaceutical Sales and Market Share by Type (2012-2017)
        10.1.2 Global Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
    10.2 Diagnostic Radioisotopes Sales Growth and Price
        10.2.1 Global Diagnostic Radioisotopes Sales Growth (2012-2017)
        10.2.2 Global Diagnostic Radioisotopes Price (2012-2017)
    10.3 Therapeutic Radioisotopes Sales Growth and Price
        10.3.1 Global Therapeutic Radioisotopes Sales Growth (2012-2017)
        10.3.2 Global Therapeutic Radioisotopes Price (2012-2017)
11 Global Radiopharmaceutical Market Segment by Application
11.1 Global Radiopharmaceutical Sales Market Share by Application (2012-2017)
    11.2 Oncology Sales Growth (2012-2017)
    11.3 Cardiology Sales Growth (2012-2017)
    11.4 Other Sales Growth (2012-2017)
12 Radiopharmaceutical Market Forecast (2017-2022)
    12.1 Global Radiopharmaceutical Sales, Revenue and Growth Rate (2017-2022)
    12.2 Radiopharmaceutical Market Forecast by Regions (2017-2022)
        12.2.1 North America Radiopharmaceutical Market Forecast (2017-2022)
        12.2.2 Europe Radiopharmaceutical Market Forecast (2017-2022)
        12.2.3 Asia-Pacific Radiopharmaceutical Market Forecast (2017-2022)
        12.2.4 South America Radiopharmaceutical Market Forecast (2017-2022)
        12.2.5 Middle East and Africa Radiopharmaceutical Market Forecast (2017-2022)
    12.3 Radiopharmaceutical Market Forecast by Type (2017-2022)
    12.4 Radiopharmaceutical Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Future Trend
    13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Analyst Introduction
    15.3 Data Source

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields


Related Reports

United States HbA1c Testing Device Market by Manufacturers, States, Type and Application, Forecast to 2022

Feb-2018 | Global Info Research | Pages : 116 | Code : MRS-215980 | 4480

HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes. Scope of the Report: This report focuses on the HbA1c Testing Device in United States market, to split the market based on manufacturers, states, type and application. Market Segment by Manufacturers, this report covers Abbott Laboratories Roche Siemens Tosoh Danaher Corporation Read more

United States Embolization Particle Market by Manufacturers, States, Type and Application, Forecast to 2022

Feb-2018 | Global Info Research | Pages : 118 | Code : MRS-215979 | 4480

Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells. Scope of the Report: This report focuses on the Embolization Particle in United States market, to split the marke Read more

United States Disposable Ostomy Bags Market by Manufacturers, States, Type and Application, Forecast to 2022

Feb-2018 | Global Info Research | Pages : 117 | Code : MRS-215978 | 4480

Disposable?Ostomy?Bags is a?prosthetic?medical device?that provides a means for the collection of waste from a surgically diverted biological system (colon,?ileum,?bladder) and the creation of a?stoma. Pouching systems are most commonly associated with?colostomies,?ileostomies, and urostomies. Scope of the Report: This report focuses on the Disposable Ostomy Bags in United States market, to split the market based on manufacturers, states, type and application. Market Segment by Man Read more

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Epileptic Seizure Monitor Alarm System Market 2018 Forecast to 2023

Feb-2018 | Global Info Research | Pages : 108 | Code : MRS-215977 | 4880

Epileptic Seizure Monitor Alarm System is a seizure-detection system that can be used long-term and in home situations for early intervention and prevention of seizure related side effects including SUDEP (sudden unexpected death in epileptic patients). Scope of the Report: This report focuses on the Epileptic Seizure Monitor Alarm System in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market base Read more

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Artificial Pancreas Devices Systems Market 2018 Forecast to 2023

Feb-2018 | Global Info Research | Pages : 104 | Code : MRS-215976 | 4880

"The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas. Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM." Scope of the Report: This report focuses on the Artificial Pancreas Devices Read more

Global Herb Oil Industry Situation and Prospects Market Research report 2017 - 2022

Jan-2018 | Stanley | Pages : 138 | Code : MRS-215427 | 2850

Summary The Global Herb Oil Industry Situation and Prospects Research report is a professional and in-depth study on the current state of the Herb Oil industry. In 2016, the world economy expanded by just 2.2 per cent, the slowest rate of growth since the Great Recession of 2009. Underpinning the sluggish global economy are the feeble pace of global investment, dwindling world trade growth, flagging productivity growth and high levels of debt. World gross product is forecast to expand Read more

Global Digestive System Drug Industry Situation and Prospects Market Research report 2017 - 2022

Jan-2018 | Stanley | Pages : 158 | Code : MRS-215426 | 2850

Summary The Global Digestive System Drug Industry Situation and Prospects Research report is a professional and in-depth study on the current state of the Digestive System Drug industry. In 2016, the world economy expanded by just 2.2 per cent, the slowest rate of growth since the Great Recession of 2009. Underpinning the sluggish global economy are the feeble pace of global investment, dwindling world trade growth, flagging productivity growth and high levels of debt. World gross pro Read more

North America and Europe Venous Stents Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Feb-2018 | Global Info Research | Pages : 103 | Code : MRS-215075 | 4480

This report studies the Venous Stents market. Venous stents are metal mesh tubes that expand against blocked or narrowed vein walls. They act as a scaffold to keep veins open. In most cases, surgeons place venous stents in larger, central veins, such as those found in the legs, chest and abdomen. Scope of the Report: This report focuses on the Venous Stents in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This rep Read more

North America and Europe Tyrosine Kinase JAK Inhibitors Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Feb-2018 | Global Info Research | Pages : 101 | Code : MRS-215074 | 4480

Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway. Scope of the Report: This report focuses on the Tyrosine Kinase JAK Inhibitors in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categor Read more

North America and Europe Acinetobacter Infections Treatment Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Feb-2018 | Global Info Research | Pages : 101 | Code : MRS-215073 | 4480

Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or “species” of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections. Scope of the Report: This report focuses on the Acinetobacter Infections Treatment in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufactu Read more

  • Payment Mode
Single User | $(USD)4880 View Pricing